Literature DB >> 18221630

Treatment of refractory bipolar depression.

Michael E Thase1.   

Abstract

Entities:  

Year:  2007        PMID： 18221630     DOI： 10.1007/s11920-007-0067-x

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  12 in total

1.  A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders.

Authors:  M A Frye; T A Ketter; T A Kimbrell; R T Dunn; A M Speer; E A Osuch; D A Luckenbaugh; G Cora-Ocatelli; G S Leverich; R M Post
Journal:  J Clin Psychopharmacol       Date:  2000-12       Impact factor: 3.153

2.  Tranylcypromine versus imipramine in anergic bipolar depression.

Authors:  J M Himmelhoch; M E Thase; A G Mallinger; P Houck
Journal:  Am J Psychiatry       Date:  1991-07       Impact factor: 18.112

Review 3.  Bipolar depression: issues in diagnosis and treatment.

Authors:  Michael E Thase
Journal:  Harv Rev Psychiatry       Date:  2005 Sep-Oct       Impact factor: 3.732

4.  Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.

Authors:  R M Post; L L Altshuler; G S Leverich; M A Frye; W A Nolen; R W Kupka; T Suppes; S McElroy; P E Keck; K D Denicoff; H Grunze; J Walden; C M R Kitchen; J Mintz
Journal:  Br J Psychiatry       Date:  2006-08       Impact factor: 9.319

5.  Subsyndromal depressive symptoms are associated with functional impairment in patients with bipolar disorder: results of a large, multisite study.

Authors:  Lori L Altshuler; Robert M Post; David O Black; Paul E Keck; Willem A Nolen; Mark A Frye; Trisha Suppes; Heinz Grunze; Ralph W Kupka; Gabriele S Leverich; Susan L McElroy; Joerg Walden; Jim Mintz
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

6.  Treatment-resistant bipolar depression: a STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone.

Authors:  Andrew A Nierenberg; Michael J Ostacher; Joseph R Calabrese; Terence A Ketter; Lauren B Marangell; David J Miklowitz; Sachiko Miyahara; Mark S Bauer; Michael E Thase; Stephen R Wisniewski; Gary S Sachs
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

7.  Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.

Authors:  Gabriele S Leverich; Lori L Altshuler; Mark A Frye; Trisha Suppes; Susan L McElroy; Paul E Keck; Ralph W Kupka; Kirk D Denicoff; Willem A Nolen; Heinz Grunze; Maria I Martinez; Robert M Post
Journal:  Am J Psychiatry       Date:  2006-02       Impact factor: 18.112

8.  Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow-up.

Authors:  Lori Altshuler; Trisha Suppes; David Black; Willem A Nolen; Paul E Keck; Mark A Frye; Susan McElroy; Ralph Kupka; Heinz Grunze; Jörg Walden; Gabrielle Leverich; Kirk Denicoff; David Luckenbaugh; Robert Post
Journal:  Am J Psychiatry       Date:  2003-07       Impact factor: 18.112

9.  Effectiveness of adjunctive antidepressant treatment for bipolar depression.

Authors:  Gary S Sachs; Andrew A Nierenberg; Joseph R Calabrese; Lauren B Marangell; Stephen R Wisniewski; Laszlo Gyulai; Edward S Friedman; Charles L Bowden; Mark D Fossey; Michael J Ostacher; Terence A Ketter; Jayendra Patel; Peter Hauser; Daniel Rapport; James M Martinez; Michael H Allen; David J Miklowitz; Michael W Otto; Ellen B Dennehy; Michael E Thase
Journal:  N Engl J Med       Date:  2007-03-28       Impact factor: 91.245

10.  Treatment of imipramine-resistant recurrent depression, IV: A double-blind crossover study of tranylcypromine for anergic bipolar depression.

Authors:  M E Thase; A G Mallinger; D McKnight; J M Himmelhoch
Journal:  Am J Psychiatry       Date:  1992-02       Impact factor: 18.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.